These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 2642920)
1. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. Natanson C; Danner RL; Elin RJ; Hosseini JM; Peart KW; Banks SM; MacVittie TJ; Walker RI; Parrillo JE J Clin Invest; 1989 Jan; 83(1):243-51. PubMed ID: 2642920 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Danner RL; Natanson C; Elin RJ; Hosseini JM; Banks S; MacVittie TJ; Parrillo JE Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691 [TBL] [Abstract][Full Text] [Related]
3. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. Natanson C; Eichenholz PW; Danner RL; Eichacker PQ; Hoffman WD; Kuo GC; Banks SM; MacVittie TJ; Parrillo JE J Exp Med; 1989 Mar; 169(3):823-32. PubMed ID: 2647895 [TBL] [Abstract][Full Text] [Related]
4. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock. Hoffman WD; Danner RL; Quezado ZM; Banks SM; Elin RJ; Hosseini JM; Natanson C Infect Immun; 1996 Feb; 64(2):406-12. PubMed ID: 8550184 [TBL] [Abstract][Full Text] [Related]
5. Antibiotics versus cardiovascular support in a canine model of human septic shock. Natanson C; Danner RL; Reilly JM; Doerfler ML; Hoffman WD; Akin GL; Hosseini JM; Banks SM; Elin RJ; MacVittie TJ Am J Physiol; 1990 Nov; 259(5 Pt 2):H1440-7. PubMed ID: 2240243 [TBL] [Abstract][Full Text] [Related]
6. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization. Manson NH; Hess ML Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. Fischer E; Marano MA; Van Zee KJ; Rock CS; Hawes AS; Thompson WA; DeForge L; Kenney JS; Remick DG; Bloedow DC J Clin Invest; 1992 May; 89(5):1551-7. PubMed ID: 1533231 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. Wakabayashi G; Gelfand JA; Jung WK; Connolly RJ; Burke JF; Dinarello CA J Clin Invest; 1991 Jun; 87(6):1925-35. PubMed ID: 2040686 [TBL] [Abstract][Full Text] [Related]
10. Alveolar macrophage function in a canine model of endotoxin-induced lung injury. Jacobs RF; Kiel DP; Balk RA Am Rev Respir Dis; 1986 Oct; 134(4):745-51. PubMed ID: 3532887 [TBL] [Abstract][Full Text] [Related]
11. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. Natanson C; Fink MP; Ballantyne HK; MacVittie TJ; Conklin JJ; Parrillo JE J Clin Invest; 1986 Jul; 78(1):259-70. PubMed ID: 3722379 [TBL] [Abstract][Full Text] [Related]
12. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia. Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355 [TBL] [Abstract][Full Text] [Related]
13. Endotoxemia in human septic shock. Danner RL; Elin RJ; Hosseini JM; Wesley RA; Reilly JM; Parillo JE Chest; 1991 Jan; 99(1):169-75. PubMed ID: 1984950 [TBL] [Abstract][Full Text] [Related]
14. Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock. Eichacker PQ; Hoffman WD; Farese A; Danner RL; Suffredini AF; Waisman Y; Banks SM; Mouginis T; Wilson L; Rothlein R J Appl Physiol (1985); 1993 Apr; 74(4):1885-92. PubMed ID: 8099906 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Natanson C; Danner RL; Fink MP; MacVittie TJ; Walker RI; Conklin JJ; Parrillo JE Am J Physiol; 1988 Mar; 254(3 Pt 2):H558-69. PubMed ID: 3279822 [TBL] [Abstract][Full Text] [Related]
16. The cardiovascular response of normal humans to the administration of endotoxin. Suffredini AF; Fromm RE; Parker MM; Brenner M; Kovacs JA; Wesley RA; Parrillo JE N Engl J Med; 1989 Aug; 321(5):280-7. PubMed ID: 2664516 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of HA-1A in a canine model of gram-negative septic shock. Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201 [TBL] [Abstract][Full Text] [Related]
18. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. Quezado ZM; Hoffman WD; Winkelstein JA; Yatsiv I; Koev CA; Cork LC; Elin RJ; Eichacker PQ; Natanson C J Exp Med; 1994 Feb; 179(2):569-78. PubMed ID: 8294868 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of vasoactive intestinal polypeptide in pigs during endotoxinaemia. Revhaug A; Lygren I; Lundgren TI; Andersen OK; Burhol PG; Giercksky KE Eur Surg Res; 1985; 17(2):75-82. PubMed ID: 3884342 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. Quezado ZM; Natanson C; Banks SM; Alling DW; Koev CA; Danner RL; Elin RJ; Hosseini JM; Parker TS; Levine DM J Pharmacol Exp Ther; 1995 Feb; 272(2):604-11. PubMed ID: 7853173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]